 | • レポートコード：MRC2012B0044 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、貧血治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。貧血治療薬の種類別市場規模（経口、注射）、用途別市場規模（鉄欠乏性貧血、慢性腎臓病関連貧血、鎌状赤血球貧血、再生不良性貧血）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline、Bayer AG、GlycoMimetics、Global Blood Therapeutics (GBT)、Akebia Therapeutics、Bluebird Bio、Regen Biopharma、Fibrogen、Mast Therapeutics、Eli Lilly、Acceleron Pharma、Pieris Pharmaceuticals、Celgene Corporation、Onconova Therapeutics、 ・地域別グローバル市場分析 2015年-2020年 ・貧血治療薬の北米市場（アメリカ、カナダ、メキシコ） ・貧血治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・貧血治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・貧血治療薬の南米市場（ブラジル、アルゼンチン） ・貧血治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：経口、注射 ・用途別分析：鉄欠乏性貧血、慢性腎臓病関連貧血、鎌状赤血球貧血、再生不良性貧血 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anemia Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 14180 million by 2025, from USD 11960 million in 2019.
The Anemia Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anemia Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anemia Drugs market has been segmented into:
Oral
Injection
By Application, Anemia Drugs has been segmented into:
Iron Deficiency Anemia
Chronic Kidney Disease related Anemia
Sickle Cell Anemia
Aplastic Anemia
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anemia Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Anemia Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anemia Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Anemia Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anemia Drugs Market Share Analysis
Anemia Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anemia Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anemia Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Anemia Drugs are:
GlaxoSmithKline
Bayer AG
GlycoMimetics
Global Blood Therapeutics (GBT)
Akebia Therapeutics
Bluebird Bio
Regen Biopharma
Fibrogen
Mast Therapeutics
Eli Lilly
Acceleron Pharma
Pieris Pharmaceuticals
Celgene Corporation
Onconova Therapeutics
Table of Contents
1 Anemia Drugs Market Overview
1.1 Product Overview and Scope of Anemia Drugs
1.2 Classification of Anemia Drugs by Type
1.2.1 Global Anemia Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anemia Drugs Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.3 Global Anemia Drugs Market by Application
1.3.1 Overview: Global Anemia Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Iron Deficiency Anemia
1.3.3 Chronic Kidney Disease related Anemia
1.3.4 Sickle Cell Anemia
1.3.5 Aplastic Anemia
1.4 Global Anemia Drugs Market by Regions
1.4.1 Global Anemia Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anemia Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anemia Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anemia Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anemia Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anemia Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anemia Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bayer AG
2.2.1 Bayer AG Details
2.2.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Bayer AG SWOT Analysis
2.2.4 Bayer AG Product and Services
2.2.5 Bayer AG Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlycoMimetics
2.3.1 GlycoMimetics Details
2.3.2 GlycoMimetics Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlycoMimetics SWOT Analysis
2.3.4 GlycoMimetics Product and Services
2.3.5 GlycoMimetics Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Global Blood Therapeutics (GBT)
2.4.1 Global Blood Therapeutics (GBT) Details
2.4.2 Global Blood Therapeutics (GBT) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Global Blood Therapeutics (GBT) SWOT Analysis
2.4.4 Global Blood Therapeutics (GBT) Product and Services
2.4.5 Global Blood Therapeutics (GBT) Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Akebia Therapeutics
2.5.1 Akebia Therapeutics Details
2.5.2 Akebia Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Akebia Therapeutics SWOT Analysis
2.5.4 Akebia Therapeutics Product and Services
2.5.5 Akebia Therapeutics Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bluebird Bio
2.6.1 Bluebird Bio Details
2.6.2 Bluebird Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bluebird Bio SWOT Analysis
2.6.4 Bluebird Bio Product and Services
2.6.5 Bluebird Bio Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Regen Biopharma
2.7.1 Regen Biopharma Details
2.7.2 Regen Biopharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Regen Biopharma SWOT Analysis
2.7.4 Regen Biopharma Product and Services
2.7.5 Regen Biopharma Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fibrogen
2.8.1 Fibrogen Details
2.8.2 Fibrogen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Fibrogen SWOT Analysis
2.8.4 Fibrogen Product and Services
2.8.5 Fibrogen Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Mast Therapeutics
2.9.1 Mast Therapeutics Details
2.9.2 Mast Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Mast Therapeutics SWOT Analysis
2.9.4 Mast Therapeutics Product and Services
2.9.5 Mast Therapeutics Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eli Lilly
2.10.1 Eli Lilly Details
2.10.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eli Lilly SWOT Analysis
2.10.4 Eli Lilly Product and Services
2.10.5 Eli Lilly Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Acceleron Pharma
2.11.1 Acceleron Pharma Details
2.11.2 Acceleron Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Acceleron Pharma SWOT Analysis
2.11.4 Acceleron Pharma Product and Services
2.11.5 Acceleron Pharma Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pieris Pharmaceuticals
2.12.1 Pieris Pharmaceuticals Details
2.12.2 Pieris Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Pieris Pharmaceuticals SWOT Analysis
2.12.4 Pieris Pharmaceuticals Product and Services
2.12.5 Pieris Pharmaceuticals Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Celgene Corporation
2.13.1 Celgene Corporation Details
2.13.2 Celgene Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Celgene Corporation SWOT Analysis
2.13.4 Celgene Corporation Product and Services
2.13.5 Celgene Corporation Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.14 Onconova Therapeutics
2.14.1 Onconova Therapeutics Details
2.14.2 Onconova Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Onconova Therapeutics SWOT Analysis
2.14.4 Onconova Therapeutics Product and Services
2.14.5 Onconova Therapeutics Anemia Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anemia Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anemia Drugs Players Market Share
3.2.2 Top 10 Anemia Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anemia Drugs Revenue and Market Share by Regions
4.2 North America Anemia Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Anemia Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anemia Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Anemia Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anemia Drugs Revenue and Growth Rate (2015-2020)
5 North America Anemia Drugs Revenue by Countries
5.1 North America Anemia Drugs Revenue by Countries (2015-2020)
5.2 USA Anemia Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Anemia Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Anemia Drugs Revenue and Growth Rate (2015-2020)
6 Europe Anemia Drugs Revenue by Countries
6.1 Europe Anemia Drugs Revenue by Countries (2015-2020)
6.2 Germany Anemia Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Anemia Drugs Revenue and Growth Rate (2015-2020)
6.4 France Anemia Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Anemia Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Anemia Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anemia Drugs Revenue by Countries
7.1 Asia-Pacific Anemia Drugs Revenue by Countries (2015-2020)
7.2 China Anemia Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Anemia Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Anemia Drugs Revenue and Growth Rate (2015-2020)
7.5 India Anemia Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anemia Drugs Revenue and Growth Rate (2015-2020)
8 South America Anemia Drugs Revenue by Countries
8.1 South America Anemia Drugs Revenue by Countries (2015-2020)
8.2 Brazil Anemia Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Anemia Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anemia Drugs by Countries
9.1 Middle East & Africa Anemia Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anemia Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Anemia Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Anemia Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Anemia Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anemia Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Anemia Drugs Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Anemia Drugs Market Segment by Application
11.1 Global Anemia Drugs Revenue Market Share by Application (2015-2020)
11.2 Anemia Drugs Market Forecast by Application (2019-2024)
11.3 Iron Deficiency Anemia Revenue Growth (2015-2020)
11.4 Chronic Kidney Disease related Anemia Revenue Growth (2015-2020)
11.5 Sickle Cell Anemia Revenue Growth (2015-2020)
11.6 Aplastic Anemia Revenue Growth (2015-2020)
12 Global Anemia Drugs Market Size Forecast (2021-2025)
12.1 Global Anemia Drugs Market Size Forecast (2021-2025)
12.2 Global Anemia Drugs Market Forecast by Regions (2021-2025)
12.3 North America Anemia Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Anemia Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anemia Drugs Revenue Market Forecast (2021-2025)
12.6 South America Anemia Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anemia Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anemia Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anemia Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anemia Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anemia Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Anemia Drugs Major Business
Table 7. GlaxoSmithKline Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline SWOT Analysis
Table 9. GlaxoSmithKline Anemia Drugs Product and Solutions
Table 10. GlaxoSmithKline Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Bayer AG Corporate Information, Location and Competitors
Table 12. Bayer AG Anemia Drugs Major Business
Table 13. Bayer AG Anemia Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Bayer AG SWOT Analysis
Table 15. Bayer AG Anemia Drugs Product and Solutions
Table 16. Bayer AG Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. GlycoMimetics Corporate Information, Location and Competitors
Table 18. GlycoMimetics Anemia Drugs Major Business
Table 19. GlycoMimetics Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 20. GlycoMimetics SWOT Analysis
Table 21. GlycoMimetics Anemia Drugs Product and Solutions
Table 22. GlycoMimetics Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Global Blood Therapeutics (GBT) Corporate Information, Location and Competitors
Table 24. Global Blood Therapeutics (GBT) Anemia Drugs Major Business
Table 25. Global Blood Therapeutics (GBT) Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Global Blood Therapeutics (GBT) SWOT Analysis
Table 27. Global Blood Therapeutics (GBT) Anemia Drugs Product and Solutions
Table 28. Global Blood Therapeutics (GBT) Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Akebia Therapeutics Corporate Information, Location and Competitors
Table 30. Akebia Therapeutics Anemia Drugs Major Business
Table 31. Akebia Therapeutics Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Akebia Therapeutics SWOT Analysis
Table 33. Akebia Therapeutics Anemia Drugs Product and Solutions
Table 34. Akebia Therapeutics Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bluebird Bio Corporate Information, Location and Competitors
Table 36. Bluebird Bio Anemia Drugs Major Business
Table 37. Bluebird Bio Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Bluebird Bio SWOT Analysis
Table 39. Bluebird Bio Anemia Drugs Product and Solutions
Table 40. Bluebird Bio Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Regen Biopharma Corporate Information, Location and Competitors
Table 42. Regen Biopharma Anemia Drugs Major Business
Table 43. Regen Biopharma Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Regen Biopharma SWOT Analysis
Table 45. Regen Biopharma Anemia Drugs Product and Solutions
Table 46. Regen Biopharma Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Fibrogen Corporate Information, Location and Competitors
Table 48. Fibrogen Anemia Drugs Major Business
Table 49. Fibrogen Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Fibrogen SWOT Analysis
Table 51. Fibrogen Anemia Drugs Product and Solutions
Table 52. Fibrogen Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Mast Therapeutics Corporate Information, Location and Competitors
Table 54. Mast Therapeutics Anemia Drugs Major Business
Table 55. Mast Therapeutics Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Mast Therapeutics SWOT Analysis
Table 57. Mast Therapeutics Anemia Drugs Product and Solutions
Table 58. Mast Therapeutics Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Eli Lilly Corporate Information, Location and Competitors
Table 60. Eli Lilly Anemia Drugs Major Business
Table 61. Eli Lilly Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Eli Lilly SWOT Analysis
Table 63. Eli Lilly Anemia Drugs Product and Solutions
Table 64. Eli Lilly Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Acceleron Pharma Corporate Information, Location and Competitors
Table 66. Acceleron Pharma Anemia Drugs Major Business
Table 67. Acceleron Pharma Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Acceleron Pharma SWOT Analysis
Table 69. Acceleron Pharma Anemia Drugs Product and Solutions
Table 70. Acceleron Pharma Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Pieris Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Pieris Pharmaceuticals Anemia Drugs Major Business
Table 73. Pieris Pharmaceuticals Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 74. Pieris Pharmaceuticals SWOT Analysis
Table 75. Pieris Pharmaceuticals Anemia Drugs Product and Solutions
Table 76. Pieris Pharmaceuticals Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Celgene Corporation Corporate Information, Location and Competitors
Table 78. Celgene Corporation Anemia Drugs Major Business
Table 79. Celgene Corporation Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 80. Celgene Corporation SWOT Analysis
Table 81. Celgene Corporation Anemia Drugs Product and Solutions
Table 82. Celgene Corporation Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Onconova Therapeutics Corporate Information, Location and Competitors
Table 84. Onconova Therapeutics Anemia Drugs Major Business
Table 85. Onconova Therapeutics Anemia Drugs Total Revenue (USD Million) (2017-2018)
Table 86. Onconova Therapeutics SWOT Analysis
Table 87. Onconova Therapeutics Anemia Drugs Product and Solutions
Table 88. Onconova Therapeutics Anemia Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Global Anemia Drugs Revenue (Million USD) by Players (2015-2020)
Table 90. Global Anemia Drugs Revenue Share by Players (2015-2020)
Table 91. Global Anemia Drugs Revenue (Million USD) by Regions (2015-2020)
Table 92. Global Anemia Drugs Revenue Market Share by Regions (2015-2020)
Table 93. North America Anemia Drugs Revenue by Countries (2015-2020)
Table 94. North America Anemia Drugs Revenue Market Share by Countries (2015-2020)
Table 95. Europe Anemia Drugs Revenue (Million USD) by Countries (2015-2020)
Table 96. Asia-Pacific Anemia Drugs Revenue (Million USD) by Countries (2015-2020)
Table 97. South America Anemia Drugs Revenue by Countries (2015-2020)
Table 98. South America Anemia Drugs Revenue Market Share by Countries (2015-2020)
Table 99. Middle East and Africa Anemia Drugs Revenue (Million USD) by Countries (2015-2020)
Table 100. Middle East and Africa Anemia Drugs Revenue Market Share by Countries (2015-2020)
Table 101. Global Anemia Drugs Revenue (Million USD) by Type (2015-2020)
Table 102. Global Anemia Drugs Revenue Share by Type (2015-2020)
Table 103. Global Anemia Drugs Revenue Forecast by Type (2021-2025)
Table 104. Global Anemia Drugs Revenue by Application (2015-2020)
Table 105. Global Anemia Drugs Revenue Share by Application (2015-2020)
Table 106. Global Anemia Drugs Revenue Forecast by Application (2021-2025)
Table 107. Global Anemia Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anemia Drugs Picture
Figure 2. Global Anemia Drugs Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Anemia Drugs Revenue Market Share by Application in 2019
Figure 6. Iron Deficiency Anemia Picture
Figure 7. Chronic Kidney Disease related Anemia Picture
Figure 8. Sickle Cell Anemia Picture
Figure 9. Aplastic Anemia Picture
Figure 10. Global Anemia Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Anemia Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Anemia Drugs Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Anemia Drugs Revenue Market Share in 2019
Figure 19. Global Top 10 Players Anemia Drugs Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Anemia Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Anemia Drugs Revenue Market Share by Regions (2015-2020)
Figure 23. Global Anemia Drugs Revenue Market Share by Regions in 2018
Figure 24. North America Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 25. Europe Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 27. South America Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 29. North America Anemia Drugs Revenue Market Share by Countries (2015-2020)
Figure 30. North America Anemia Drugs Revenue Market Share by Countries in 2019
Figure 31. USA Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Canada Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Europe Anemia Drugs Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Anemia Drugs Revenue Market Share by Countries in 2019
Figure 36. Germany Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 37. UK Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 38. France Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 39. Russia Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 40. Italy Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Anemia Drugs Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Anemia Drugs Revenue Market Share by Countries in 2019
Figure 43. China Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Japan Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Korea Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 46. India Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 48. South America Anemia Drugs Revenue Market Share by Countries (2015-2020)
Figure 49. South America Anemia Drugs Revenue Market Share by Countries in 2019
Figure 50. Brazil Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Anemia Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Anemia Drugs Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 55. UAE Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Anemia Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Global Anemia Drugs Revenue Share by Type (2015-2020)
Figure 59. Global Anemia Drugs Revenue Share by Type in 2019
Figure 60. Global Anemia Drugs Market Share Forecast by Type (2021-2025)
Figure 61. Global Oral Revenue Growth Rate (2015-2020)
Figure 62. Global Injection Revenue Growth Rate (2015-2020)
Figure 63. Global Anemia Drugs Revenue Share by Application (2015-2020)
Figure 64. Global Anemia Drugs Revenue Share by Application in 2019
Figure 65. Global Anemia Drugs Market Share Forecast by Application (2021-2025)
Figure 66. Global Iron Deficiency Anemia Revenue Growth Rate (2015-2020)
Figure 67. Global Chronic Kidney Disease related Anemia Revenue Growth Rate (2015-2020)
Figure 68. Global Sickle Cell Anemia Revenue Growth Rate (2015-2020)
Figure 69. Global Aplastic Anemia Revenue Growth Rate (2015-2020)
Figure 70. Global Anemia Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Anemia Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Anemia Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Anemia Drugs Revenue Market Forecast (2021-2025)
Figure 74. Europe Anemia Drugs Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Anemia Drugs Revenue Market Forecast (2021-2025)
Figure 76. South America Anemia Drugs Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Anemia Drugs Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
貧血治療薬の世界市場（～2026年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 貧血・ビタミン検査の世界市場（～2026年） Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or lo…
- ファンコニ貧血治療薬の世界市場（～2026年） Market Analysis and Insights: Global Fanconi Anemia Drug Market The global Fanconi Anemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Fanconi Anemia Drug Scope and Market Size Fanconi Anemia Drug market is seg…